COMMUNIQUÉS West-GlobeNewswire

Bespoke Extracts Engages Daniel M. Slane to Spearhead New Business Development Initiatives in Key International Markets
20/08/2018
SUNNY ISLES, Fla., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (OTCQB: BSPK), producer of high quality, great tasting, hemp-derived CBD extract products, today announced the engagement of Daniel M. Slane as [...]
Easton Pharmaceuticals Acquires Interest in Development Project With in Excess of $30 Million in Profit
20/08/2018
TORONTO, ON, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Easton Pharmaceuticals Inc. (OTC: EAPH) announces that it has entered into an Agreement to acquire an interest in a Real Estate Development Project just outside of Toronto [...]
Sanofi: Disclosure of trading in own shares
20/08/2018
Attachment Reporting EN.pdf
Sanofi : Déclaration des transactions sur actions propres
20/08/2018
Pièce jointe Reporting FR.pdf
Ossur Hf : Transactions in relation to share buyback program
20/08/2018
Announcement no. 51/2018 19 August 2018 Transactions in relation to share buyback program On 5 March 2018, Össur hf. initiated a share buy-back program, see Company announcement no. 16/2018. The purpose of the share [...]
Grant of Warrants
20/08/2018
August 20, 2018 Announcement no. 15 In accordance with the company's guidelines relating to incentive remuneration and the authorization in Section 18 of the Articles of Association, the Board of Directors of BioPorto A [...]
Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test
20/08/2018
Albuquerque and San Diego, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Exagen Diagnostics Announces Evidence Development Agreement with a Large Mid-Atlantic Health Insurer for the AVISE® Lupus Test, see full press release here . [...]
GUERBET : Information sur les opération effectuées dans le cadre du programme de rachat d'actions
20/08/2018
Villepinte (France), le 20 août 2018 Le présent document a pour finalité de présenter les opérations réalisées dans le cadre du programme de rachat d'actions autorisé par l'Assemblée Générale Mixte du 25 mai 2018 sur la [...]
Altasciences Initiates Expansion of Bioanalytical Laboratory
20/08/2018
LAVAL, Quebec, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Altasciences announced today that construction work has begun on the expansion of their ligand binding laboratory to meet the high demand for quality bioanalytical [...]
Altasciences lance les travaux d'agrandissement de son laboratoire bioanalytique
20/08/2018
LAVAL, Québec, 20 août 2018 (GLOBE NEWSWIRE) -- Altasciences a annoncé aujourd’hui qu’elle a entamé les travaux d’agrandissement de son laboratoire d’essais de liaison aux ligands, afin de répondre à la demande élevée [...]
Captor Capital: Building a Vertically-Integrated Cannabis Empire -- CFN Media
20/08/2018
SEATTLE, WA, Aug. 20, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an article [...]
Golden Leaf Holdings to Hold Conference Call to Review Second Quarter 2018 Results
20/08/2018
PORTLAND, Ore., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. ("GLH" or the "Company") (CSE:GLH) (OTCQB:GLDFF), a cannabis company with cultivation, production and retail operations built around recognized [...]
Novo Nordisk A/S - Share repurchase programme
20/08/2018
Bagsværd, Denmark, 20 August 2018 - On 10 August 2018, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No. 596/2014 of the European Parliament and Council of 16 April 2014 [...]
Acer Therapeutics to Present at the 20th Annual H.C. Wainwright Conference
20/08/2018
NEWTON, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Acer Therapeutics Inc. (Nasdaq: ACER), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and ultra-rare [...]
Newly Published Data Show Daxor Corporation's BVA-100 Is Superior To Formula-Based Estimates of Blood Volume In Assessing Patients With Heart Failure
20/08/2018
NEW YORK, Aug. 20, 2018 (GLOBE NEWSWIRE) -- Daxor Corporation (NYSE MKT: DXR) , an innovative medical instrumentation and biotechnology company focused on blood volume measurement today announces the publication of an [...]
Sarepta Therapeutics Announces Recipients of Route 79, The Duchenne Scholarship Program
20/08/2018
-- 10 academic scholarships awarded to students diagnosed with Duchenne muscular dystrophy as they pursue their post-secondary education this fall -- CAMBRIDGE, Mass., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Sarepta [...]
Fractionated Dosing Improves Tolerability and Safety of Cellectar’s CLR 131 in R/R Multiple Myeloma Patients
20/08/2018
Positive Results from Cohort 5 of Phase 1b Trial Company Intends to Initiate a Sixth Cohort and Transition Ongoing Phase 2 Trial to a Fractionated Dose MADISON, Wis., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Cellectar [...]
Taiwan Liposome Company Reports Positive Top-Line Data from Phase II Clinical Trial of TLC599 in Knee Osteoarthritis Pain
20/08/2018
Primary endpoint and key secondary endpoints met TLC599 demonstrated statistically significant improvement over placebo through Weeks 12, 16, 20, and 24 TLC599 was well-tolerated with no treatment-related serious [...]
Catalyst Pharmaceuticals Appoints Dr. Stanley Iyadurai as Vice President of Clinical Development
20/08/2018
CORAL GABLES, Fla., Aug. 20, 2018 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. (Catalyst) (Nasdaq: CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with [...]

Pages